Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A. Burger, Thomas J. Kipps, Osnat Bairey et al.|New England Journal of Medicine|2015Cited by 1.6k
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic LeukemiaWilliam G. Wierda, Anders Österborg, Thomas J. Kipps et al.|Journal of Clinical Oncology|2010Cited by 587
Evaluation of the effect of tumour size on outcomes for patients undergoing adrenalectomy for phaeochromocytoma: international multicentre analysisSteffane McLennan, Reza Djafarrian, Kevin Verhoeff et al.|BJS Open|2025Cited by 0